KIMS Hospitals has announced that its Board of Directors approved a merger between two wholly-owned subsidiaries, KIMS Hospitals Private Limited and Chalasani Hospitals Private Limited, with the parent company, Krishna Institute of Medical Sciences Limited, as the transferee. The decision was made during a board meeting on November 7, 2025. Unaudited financial results for Q2 and H1 2026 were also approved.
Subsidiary Merger Approved
The Board of Directors at KIMS Hospitals approved the merger of its wholly-owned subsidiaries. KIMS Hospitals Private Limited and Chalasani Hospitals Private Limited will merge into the parent company, Krishna Institute of Medical Sciences Limited. The decision was made at a board meeting held on November 7, 2025.
Financial Results Approved
The board also approved the unaudited standalone and consolidated financial results for the second quarter (Q2 – July-September) and half-year ended September 30, 2025. These results have been reviewed by the Audit Committee.
Q2 & Half-Year Financial Performance (Standalone)
Total Income for the quarter ended September 30, 2025, stood at ₹4,425 million, compared to ₹3,699 million in the corresponding quarter of the previous year. Profit after tax for the quarter was ₹635 million. For the half-year ended September 30, 2025, Total Income was ₹8,281 million and Profit after tax stood at ₹1,223 million.
Q2 & Half-Year Financial Performance (Consolidated)
Total Income for the quarter ended September 30, 2025, was ₹9,649 million, compared to ₹7,823 million for the quarter ended September 30, 2024. Profit after tax was ₹720 million. For the half-year ended September 30, 2025, Total Income stood at ₹18,436 million and Profit after tax at ₹1,570 million.
Source: BSE
